X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (30647) 30647
Publication (1643) 1643
Book Review (356) 356
Magazine Article (109) 109
Book Chapter (98) 98
Book / eBook (82) 82
Conference Proceeding (72) 72
Web Resource (34) 34
Dissertation (20) 20
Reference (12) 12
Paper (5) 5
Journal / eJournal (4) 4
Data Set (2) 2
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (26458) 26458
fibrinolytic agents - therapeutic use (17720) 17720
male (12808) 12808
female (11496) 11496
index medicus (9293) 9293
middle aged (8471) 8471
aged (8032) 8032
fibrinolytic agents - administration & dosage (6984) 6984
treatment outcome (6064) 6064
animals (5673) 5673
adult (4962) 4962
fibrinolytic agents - adverse effects (4527) 4527
peripheral vascular disease (4470) 4470
thrombolytic therapy (4410) 4410
fibrinolytic agents - pharmacology (4376) 4376
tissue plasminogen activator - therapeutic use (3908) 3908
time factors (3847) 3847
risk factors (3805) 3805
cardiac & cardiovascular systems (3387) 3387
stroke (3339) 3339
myocardial infarction - drug therapy (3291) 3291
thrombolysis (3165) 3165
aged, 80 and over (3101) 3101
stroke - drug therapy (3097) 3097
anticoagulants - therapeutic use (3005) 3005
clinical neurology (2809) 2809
hematology (2706) 2706
thrombolytic therapy - methods (2484) 2484
thrombosis (2348) 2348
retrospective studies (2339) 2339
tissue plasminogen activator - administration & dosage (2278) 2278
therapy (2236) 2236
medicine, general & internal (2055) 2055
heparin - therapeutic use (2032) 2032
surgery (2017) 2017
thrombosis - drug therapy (1982) 1982
platelet aggregation inhibitors - therapeutic use (1959) 1959
fibrinolytic agents (1793) 1793
acute disease (1779) 1779
fibrinolysis (1758) 1758
rats (1752) 1752
prospective studies (1719) 1719
aspirin - therapeutic use (1656) 1656
pharmacology & pharmacy (1640) 1640
mortality (1622) 1622
brain ischemia - drug therapy (1610) 1610
care and treatment (1576) 1576
anticoagulants (1539) 1539
follow-up studies (1538) 1538
drug therapy, combination (1527) 1527
tissue plasminogen activator (1496) 1496
management (1463) 1463
acute ischemic-stroke (1444) 1444
streptokinase - therapeutic use (1431) 1431
heparin (1391) 1391
myocardial infarction - therapy (1367) 1367
aspirin (1365) 1365
tissue-plasminogen activator (1360) 1360
prognosis (1342) 1342
risk (1329) 1329
prevention (1313) 1313
acute myocardial-infarction (1302) 1302
trial (1297) 1297
abridged index medicus (1281) 1281
hemorrhage - chemically induced (1276) 1276
thrombosis - prevention & control (1268) 1268
dose-response relationship, drug (1234) 1234
clinical trials as topic (1228) 1228
risk assessment (1216) 1216
electrocardiography (1201) 1201
randomized controlled trials as topic (1187) 1187
neurosciences (1181) 1181
pulmonary embolism - drug therapy (1178) 1178
thrombolytic therapy - adverse effects (1169) 1169
drug therapy (1157) 1157
ischemia (1146) 1146
recombinant proteins - therapeutic use (1130) 1130
recurrence (1072) 1072
analysis (1059) 1059
tissue plasminogen activator - adverse effects (1057) 1057
stroke - etiology (1035) 1035
rabbits (1029) 1029
blood coagulation - drug effects (1027) 1027
anticoagulants - administration & dosage (1026) 1026
adolescent (1024) 1024
alteplase (1015) 1015
disease models, animal (1011) 1011
infusions, intravenous (997) 997
medicine & public health (993) 993
myocardial infarction - mortality (990) 990
platelet aggregation - drug effects (979) 979
thrombosis - etiology (971) 971
tomography, x-ray computed (970) 970
molecular-weight heparin (946) 946
neurology (932) 932
anticoagulants - adverse effects (926) 926
mice (922) 922
stroke - prevention & control (922) 922
thromboembolism (921) 921
heparin, low-molecular-weight - therapeutic use (895) 895
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (62) 62
Online Resources - Online (31) 31
Collection Dvlpm't (Acquisitions) - Vendor file (6) 6
Gerstein Science - Periodical Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
UofT at Mississauga - Stacks (2) 2
Gerstein Science - Theses (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Mt Sinai Hospital - Online (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Online (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
UTL at Downsview - May be requested (1) 1
University Archives - Archives (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (25821) 25821
German (1135) 1135
French (894) 894
Russian (688) 688
Spanish (503) 503
Italian (421) 421
Japanese (338) 338
Chinese (279) 279
Polish (197) 197
Danish (99) 99
Norwegian (78) 78
Portuguese (73) 73
Swedish (71) 71
Dutch (70) 70
Hungarian (65) 65
Finnish (45) 45
Czech (40) 40
Turkish (34) 34
Romanian (28) 28
Ukrainian (24) 24
Bulgarian (23) 23
Hebrew (21) 21
Serbian (13) 13
Croatian (12) 12
Korean (12) 12
Lithuanian (9) 9
Slovak (7) 7
Icelandic (2) 2
Afrikaans (1) 1
Bosnian (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


CIRCULATION, ISSN 0009-7322, 10/2015, Volume 132, Issue 14, pp. 1354 - 1364
Journal Article
Trends in Biotechnology, ISSN 0167-7799, 2004, Volume 22, Issue 3, pp. 142 - 146
The main commercial use of biosurfactants is in pollution remediation because of their ability to stabilize emulsions. This enhances the solubility and... 
IN-VITRO | ITURIN-A | ANTIBIOTICS | ACTIVATION | BACILLUS-SUBTILIS | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | ENHANCEMENT | MANNOSYLERYTHRITOL LIPIDS | BIOSURFACTANTS | GENE TRANSFECTION | PLASMINOGEN | Fibrinolysis - drug effects | Surface-Active Agents - therapeutic use | Antibiotics, Antineoplastic - pharmacology | Gram-Positive Bacteria - drug effects | Anti-Infective Agents - pharmacology | Humans | Peptides, Cyclic - pharmacology | Peptides, Cyclic - chemistry | Antifungal Agents - therapeutic use | Anti-Bacterial Agents - therapeutic use | Anti-Infective Agents - chemistry | Fibrinolytic Agents - therapeutic use | Glycolipids - chemistry | Bacterial Adhesion - drug effects | Antifungal Agents - pharmacology | Antiviral Agents - pharmacology | Peptides - chemistry | Antiviral Agents - therapeutic use | Glycolipids - pharmacology | Anti-Infective Agents - therapeutic use | Peptides - pharmacology | Surface-Active Agents - pharmacology | Fibrinolytic Agents - pharmacology | Antibiotics, Antineoplastic - therapeutic use | Cell Differentiation - drug effects | Lipoproteins - pharmacology | Peptides, Cyclic - therapeutic use | Anti-Bacterial Agents - pharmacology | Surface-Active Agents - chemistry | Lipopeptides | Peptides - therapeutic use | Salmonella | Signal transduction | Probiotics | E coli | Herpes viruses | Antimicrobial agents | Lipids | Genetic engineering | Drug resistance | Surfactants | Bacteriology
Journal Article
Current Medicinal Chemistry, ISSN 0929-8673, 07/2007, Volume 14, Issue 17, pp. 1829 - 1852
Journal Article
Current Medicinal Chemistry, ISSN 0929-8673, 08/2015, Volume 22, Issue 24, pp. 2819 - 2857
Heterocyclic N-oxides have emerged as potent compounds with anticancer, antibacterial, antihypertensive, antiparasitic, anti-HIV, anti-inflammatory,... 
Antichagasic agents | Heterocyclic N-oxides | Bioisosteres | Factor xa inhibitors | Antimalarials | Hypoxia | Nitric oxide mimics | Coagulation cascade direct thrombin inhibitors | hypoxia | TRANSITION-METAL CATALYSIS | BETA-AMINOESTER CLASS | CHEMISTRY, MEDICINAL | ACTIVATED PROTEIN-KINASE | antichagasic agents | K-ATP CHANNELS | BIOCHEMISTRY & MOLECULAR BIOLOGY | antimalarials | HUMAN-LEUKOCYTE ELASTASE | coagulation cascade direct thrombin inhibitors | CARBON BOND FORMATION | 1,3-DIOXIDE CORE SCAFFOLDS | HIV-1 ENTRY INHIBITORS | PHARMACOLOGY & PHARMACY | bioisosteres | factor Xa inhibitors | LONG-TERM POTENTIATION | FACTOR XA INHIBITOR | nitric oxide mimics | Anti-HIV Agents - pharmacology | Neuroprotective Agents - therapeutic use | Antihypertensive Agents - pharmacology | Humans | Antineoplastic Agents - therapeutic use | Herbicides - pharmacology | Antihypertensive Agents - therapeutic use | Anti-Bacterial Agents - therapeutic use | Fibrinolytic Agents - pharmacology | Cyclic N-Oxides - therapeutic use | Animals | Neuroprotective Agents - pharmacology | Cyclic N-Oxides - pharmacology | Protein Kinase Inhibitors - therapeutic use | Fibrinolytic Agents - therapeutic use | Anti-HIV Agents - therapeutic use | Anti-Bacterial Agents - pharmacology | Antineoplastic Agents - pharmacology | Protein Kinase Inhibitors - pharmacology
Journal Article
Journal Article
Gastrointestinal Endoscopy, ISSN 0016-5107, 2016, Volume 83, Issue 1, pp. 3 - 16
Journal Article
Journal Article
Mini-Reviews in Medicinal Chemistry, ISSN 1389-5575, 2014, Volume 14, Issue 4, pp. 355 - 369
In the present article synthesis and medicinal applications of [1, 2, 4] oxadiazoles are reviewed. The oxadiazoles have a wide range of applications such as... 
Heterocycles | Anti-tumor agents | Synthetic methods | Anti-inflammatory | [1,2,4] oxadiazoles | Anaesthetic angent | One pot synthesis | CONVENIENT SYNTHESIS | CHEMISTRY, MEDICINAL | NONQUATERNARY CHOLINESTERASE REACTIVATORS | ONE-POT SYNTHESIS | 2,5-DISUBSTITUTED 1,3,4-OXADIAZOLES | MICROWAVE IRRADIATION | ACETYLCHOLINESTERASE INVITRO | anti-tumor agents | one pot synthesis | SOLVENT-FREE | heterocycles | anti-inflammatory | ANTIPROTOZOAL ACTIVITY | synthetic methods | 1,2,4-OXADIAZOLE DERIVATIVES | PHARMACOLOGICAL-PROPERTIES | Fibrinolytic Agents - chemistry | Vasodilator Agents - therapeutic use | Apoptosis - drug effects | Antineoplastic Agents - chemical synthesis | Anesthetics - pharmacology | Hypersensitivity - drug therapy | Antineoplastic Agents - toxicity | Platelet Aggregation Inhibitors - chemical synthesis | Oxadiazoles - pharmacology | Fibrinolytic Agents - therapeutic use | Anesthetics - chemical synthesis | Platelet Aggregation Inhibitors - pharmacology | Vasodilator Agents - chemical synthesis | Fibrinolytic Agents - chemical synthesis | Blood Platelets - drug effects | Oxadiazoles - chemistry | Venous Thrombosis - drug therapy | Anesthetics - chemistry | Anti-Inflammatory Agents - pharmacology | Antineoplastic Agents - chemistry | Oxadiazoles - therapeutic use | Animals | Anti-Inflammatory Agents - chemistry | Platelet Aggregation Inhibitors - chemistry | Vasodilator Agents - chemistry | Anti-Inflammatory Agents - chemical synthesis
Journal Article
2003, 2nd ed., rev. and expanded., Fundamental and clinical cardiology, ISBN 9780824707958, Volume 46, 830
Presents new chapters discussing the latest research on low-molecular-weight heparins, as well as agents such as pentasaccharide, TFP1, soluble thrombomodulin,... 
drug effects | drug therapy | Hemostasis | Thrombosis | Fibrinolytic agents | Thrombolytic therapy
eBook
2006, Clinics in geriatric medicine, ISBN 1416035001, Volume 22 no. 1., xiv, 219
Book